This bill amends the New Hampshire Vaccine Association's (NHVA) operations by requiring that funds collected through assessments be disbursed by the end of each fiscal year, to the extent practicable, and not exceeding 90 days thereafter. It introduces a new paragraph to RSA 126-Q:5, stating that assessments, including those deposited in the state vaccine purchase fund, must be disbursed accordingly. Additionally, the bill modifies RSA 126-Q:3, V(m) to specify that assessments will be deposited annually with the state treasurer for the vaccine purchase fund, while also allowing for the return of unexpended funds to the association upon request.

Furthermore, the bill establishes a committee tasked with studying the efficacy of the NHVA, comprising three members from the House of Representatives and two from the Senate. The committee is authorized to gather information and testimony relevant to its study and must report its findings and recommendations by November 1, 2026. The bill's effective date is set for 60 days after passage for sections 1 and 2, while the remainder takes effect upon passage. The fiscal impact of the bill includes a projected $24 million decrease in NHVA revenue and expenditures, as the NHVA's role in vaccine purchasing is diminished, potentially leading to increased healthcare costs and insurance premiums.

Statutes affected:
As Amended by the House: 126-Q:3